Home

Download

Statistics

Examples

Help

Contact

Editing gene: PFDN5 (CAeditome ID:5204)

Gene summary for PFDN5

Gene summary

Gene information	Gene symbol	PFDN5
	Gene ID	5204
	Gene name	prefoldin subunit 5
	Synonyms	MM-1\|MM1\|PFD5
	Cytomap	12q13.13
	Type of gene	protein-coding
	Description	prefoldin subunit 5c-myc binding proteinmyc modulator-1
	Modification date	20210518
	UniProtAcc	Q99471
	Context

Gene ontology of each this gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Gene	GO ID	GO term	PubMed ID
PFDN5	GO:0001540	Prefoldin subunit 5	23614719
PFDN5	GO:0051082	Prefoldin subunit 5	30955883
PFDN5	GO:0006457	Prefoldin subunit 5	30955883
PFDN5	GO:1905907	Prefoldin subunit 5	23614719
PFDN5	GO:0005829	Prefoldin subunit 5	0000052
PFDN5	GO:0045111	Prefoldin subunit 5	0000052
PFDN5	GO:0016272	Prefoldin subunit 5	23614719
PFDN5	GO:0016272	Prefoldin subunit 5	30955883

Top

RNA A-to-I events for PFDN5

RNA A-to-I editing events across TCGA 33 cancers data sets based on Ensembl gene isoform structure.

RNA editing frequencies across 33 cancers of gene: ENSG00000123349.12

RNA A-to-I editing events in Cancer.

CAediting_892883(53296435, +), CAediting_892884(53296464, +), CAediting_892885(53296471, +), CAediting_892886(53296489, +), CAediting_892887(53296508, +), CAediting_892888(53296509, +), CAediting_892889(53296511, +), CAediting_892890(53296550, +), CAediting_892891(53296554, +), CAediting_892892(53296561, +), CAediting_892893(53296583, +), CAediting_892894(53296589, +), CAediting_892895(53296592, +), CAediting_892896(53296610, +), CAediting_892897(53296612, +), CAediting_892898(53296619, +), CAediting_892899(53296676, +), CAediting_892900(53296696, +), CAediting_892901(53296700, +), CAediting_892902(53297119, +), CAediting_892903(53297147, +), CAediting_892904(53297151, +), CAediting_892905(53297157, +), CAediting_892906(53297174, +), CAediting_892907(53297179, +), CAediting_892908(53297195, +), CAediting_892909(53297204, +), CAediting_892910(53297219, +), CAediting_892911(53297226, +), CAediting_892912(53297267, +), CAediting_892913(53297275, +), CAediting_892914(53297276, +), CAediting_892915(53297277, +), CAediting_892916(53297278, +), CAediting_892917(53297279, +), CAediting_892918(53297282, +), CAediting_892919(53297286, +), CAediting_892920(53297298, +), CAediting_892921(53297300, +), CAediting_892922(53297308, +), CAediting_892923(53297309, +), CAediting_892924(53297314, +), CAediting_892925(53297318, +), CAediting_892926(53297331, +), CAediting_892927(53297341, +), CAediting_892928(53297349, +), CAediting_892929(53297355, +), CAediting_892930(53297357, +), CAediting_892931(53297361, +), CAediting_892932(53297394, +), CAediting_892933(53297400, +), CAediting_892934(53297411, +), CAediting_892935(53297413, +),

Top

RNA editing positional annotations for PFDN5 using Annovar

Protein coding RNA editing(s).

CAeditome ID

Position

Variant type

ENST

NTchange

AAchange

SIFT_score

Polyphen2_HVAR_score

PROVEAN_pred

Gene structure information of RNA editing(s).

CAeditome ID	Position	Variant type
CAediting_892883	chr12_53296435_+	exonic
CAediting_892884	chr12_53296464_+	exonic
CAediting_892885	chr12_53296471_+	exonic
CAediting_892886	chr12_53296489_+	ncRNA_exonic
CAediting_892887	chr12_53296508_+	ncRNA_exonic
CAediting_892888	chr12_53296509_+	ncRNA_exonic
CAediting_892889	chr12_53296511_+	ncRNA_exonic
CAediting_892890	chr12_53296550_+	ncRNA_exonic
CAediting_892891	chr12_53296554_+	ncRNA_exonic
CAediting_892892	chr12_53296561_+	ncRNA_exonic
CAediting_892893	chr12_53296583_+	ncRNA_exonic
CAediting_892894	chr12_53296589_+	ncRNA_exonic
CAediting_892895	chr12_53296592_+	ncRNA_exonic
CAediting_892896	chr12_53296610_+	ncRNA_exonic
CAediting_892897	chr12_53296612_+	ncRNA_exonic
CAediting_892898	chr12_53296619_+	ncRNA_exonic
CAediting_892899	chr12_53296676_+	ncRNA_exonic
CAediting_892900	chr12_53296696_+	ncRNA_exonic
CAediting_892901	chr12_53296700_+	ncRNA_exonic
CAediting_892902	chr12_53297119_+	ncRNA_exonic
CAediting_892903	chr12_53297147_+	ncRNA_exonic
CAediting_892904	chr12_53297151_+	ncRNA_exonic
CAediting_892905	chr12_53297157_+	ncRNA_exonic
CAediting_892906	chr12_53297174_+	ncRNA_exonic
CAediting_892907	chr12_53297179_+	ncRNA_exonic
CAediting_892908	chr12_53297195_+	ncRNA_exonic
CAediting_892909	chr12_53297204_+	ncRNA_exonic
CAediting_892910	chr12_53297219_+	ncRNA_exonic
CAediting_892911	chr12_53297226_+	ncRNA_exonic
CAediting_892912	chr12_53297267_+	ncRNA_exonic
CAediting_892913	chr12_53297275_+	ncRNA_exonic
CAediting_892914	chr12_53297276_+	ncRNA_exonic
CAediting_892915	chr12_53297277_+	ncRNA_exonic
CAediting_892916	chr12_53297278_+	ncRNA_exonic
CAediting_892917	chr12_53297279_+	ncRNA_exonic
CAediting_892918	chr12_53297282_+	ncRNA_exonic
CAediting_892919	chr12_53297286_+	ncRNA_exonic
CAediting_892920	chr12_53297298_+	ncRNA_exonic
CAediting_892921	chr12_53297300_+	ncRNA_exonic
CAediting_892922	chr12_53297308_+	ncRNA_exonic
CAediting_892923	chr12_53297309_+	ncRNA_exonic
CAediting_892924	chr12_53297314_+	ncRNA_exonic
CAediting_892925	chr12_53297318_+	ncRNA_exonic
CAediting_892926	chr12_53297331_+	ncRNA_exonic
CAediting_892927	chr12_53297341_+	ncRNA_exonic
CAediting_892928	chr12_53297349_+	ncRNA_exonic
CAediting_892929	chr12_53297355_+	ncRNA_exonic
CAediting_892930	chr12_53297357_+	ncRNA_exonic
CAediting_892931	chr12_53297361_+	ncRNA_exonic
CAediting_892932	chr12_53297394_+	ncRNA_exonic
CAediting_892933	chr12_53297400_+	ncRNA_exonic
CAediting_892934	chr12_53297411_+	ncRNA_exonic
CAediting_892935	chr12_53297413_+	ncRNA_exonic

Repat-regional RNA editing(s).

CAeditome ID	Position	Repeat family	Repeat sub family	Repeat name
CAediting_892883	chr12_53296435_+	SINE	Alu	AluSx4
CAediting_892884	chr12_53296464_+	SINE	Alu	AluSx4
CAediting_892885	chr12_53296471_+	SINE	Alu	AluSx4
CAediting_892886	chr12_53296489_+	SINE	Alu	AluSx4
CAediting_892887	chr12_53296508_+	SINE	Alu	AluSx4
CAediting_892888	chr12_53296509_+	SINE	Alu	AluSx4
CAediting_892889	chr12_53296511_+	SINE	Alu	AluSx4
CAediting_892890	chr12_53296550_+	SINE	Alu	AluSx4
CAediting_892891	chr12_53296554_+	SINE	Alu	AluSx4
CAediting_892892	chr12_53296561_+	SINE	Alu	AluSx4
CAediting_892893	chr12_53296583_+	SINE	Alu	AluSx4
CAediting_892894	chr12_53296589_+	SINE	Alu	AluSx4
CAediting_892895	chr12_53296592_+	SINE	Alu	AluSx4
CAediting_892896	chr12_53296610_+	SINE	Alu	AluSx4
CAediting_892897	chr12_53296612_+	SINE	Alu	AluSx4
CAediting_892898	chr12_53296619_+	SINE	Alu	AluSx4
CAediting_892899	chr12_53296676_+	SINE	Alu	AluSx4
CAediting_892900	chr12_53296696_+	SINE	Alu	AluSx4
CAediting_892901	chr12_53296700_+	SINE	Alu	AluSx4
CAediting_892904	chr12_53297151_+	SINE	Alu	AluSx
CAediting_892905	chr12_53297157_+	SINE	Alu	AluSx
CAediting_892906	chr12_53297174_+	SINE	Alu	AluSx
CAediting_892907	chr12_53297179_+	SINE	Alu	AluSx
CAediting_892908	chr12_53297195_+	SINE	Alu	AluSx
CAediting_892909	chr12_53297204_+	SINE	Alu	AluSx
CAediting_892910	chr12_53297219_+	SINE	Alu	AluSx
CAediting_892911	chr12_53297226_+	SINE	Alu	AluSx
CAediting_892912	chr12_53297267_+	SINE	Alu	AluSx
CAediting_892913	chr12_53297275_+	SINE	Alu	AluSx
CAediting_892914	chr12_53297276_+	SINE	Alu	AluSx
CAediting_892915	chr12_53297277_+	SINE	Alu	AluSx
CAediting_892916	chr12_53297278_+	SINE	Alu	AluSx
CAediting_892917	chr12_53297279_+	SINE	Alu	AluSx
CAediting_892918	chr12_53297282_+	SINE	Alu	AluSx
CAediting_892919	chr12_53297286_+	SINE	Alu	AluSx
CAediting_892920	chr12_53297298_+	SINE	Alu	AluSx
CAediting_892921	chr12_53297300_+	SINE	Alu	AluSx
CAediting_892922	chr12_53297308_+	SINE	Alu	AluSx
CAediting_892923	chr12_53297309_+	SINE	Alu	AluSx
CAediting_892924	chr12_53297314_+	SINE	Alu	AluSx
CAediting_892925	chr12_53297318_+	SINE	Alu	AluSx
CAediting_892926	chr12_53297331_+	SINE	Alu	AluSx
CAediting_892927	chr12_53297341_+	SINE	Alu	AluSx
CAediting_892928	chr12_53297349_+	SINE	Alu	AluSx
CAediting_892929	chr12_53297355_+	SINE	Alu	AluSx
CAediting_892930	chr12_53297357_+	SINE	Alu	AluSx
CAediting_892931	chr12_53297361_+	SINE	Alu	AluSx
CAediting_892932	chr12_53297394_+	SINE	Alu	AluSx
CAediting_892933	chr12_53297400_+	SINE	Alu	AluSx
CAediting_892934	chr12_53297411_+	SINE	Alu	AluSx
CAediting_892935	chr12_53297413_+	SINE	Alu	AluSx

Top

RNA A-to-I editing events in the alternative splicing sites for PFDN5

RNA A-to-I editing(s) in the alternative splicing sites.

AStype	CAeditomID	Editing position	AS position	AS direction	Exonic location	Wildtype sequence	Wildtype splicing strength	RNA edited sequence	RNA edited splicing strength
ES	CAediting_892883	chr12_53296435_+	53296433:53296455	3SS	0+18i	GAATTTCGCTCTGTCGCCCAGGC	-10.08	GAGTTTCGCTCTGTCGCCCAGGC	-9.94
IR	CAediting_892883	chr12_53296435_+	53296433:53296455	3SS	0+18i	GAATTTCGCTCTGTCGCCCAGGC	-10.08	GAGTTTCGCTCTGTCGCCCAGGC	-9.94
MEX_2	CAediting_892883	chr12_53296435_+	53296433:53296455	3SS	0+18i	GAATTTCGCTCTGTCGCCCAGGC	-10.08	GAGTTTCGCTCTGTCGCCCAGGC	-9.94
ES	CAediting_892885	chr12_53296471_+	53296465:53296473	5SS	0+4i	ATGGTGAGA	7.23	ATGGTGGGA	2.88
IR	CAediting_892885	chr12_53296471_+	53296465:53296473	5SS	0+4i	ATGGTGAGA	7.23	ATGGTGGGA	2.88
MEX_2	CAediting_892885	chr12_53296471_+	53296465:53296473	5SS	0+4i	ATGGTGAGA	7.23	ATGGTGGGA	2.88
ES	CAediting_892890	chr12_53296550_+	53296549:53296557	5SS	2+0i	TAGGTACGC	7.84	TGGGTACGC	6.74
IR	CAediting_892890	chr12_53296550_+	53296549:53296557	5SS	2+0i	TAGGTACGC	7.84	TGGGTACGC	6.74
MEX_2	CAediting_892890	chr12_53296550_+	53296549:53296557	5SS	2+0i	TAGGTACGC	7.84	TGGGTACGC	6.74
ES	CAediting_892891	chr12_53296554_+	53296549:53296557	5SS	0+3i	TAGGTACGC	7.84	TAGGTGCGC	6.17
IR	CAediting_892891	chr12_53296554_+	53296549:53296557	5SS	0+3i	TAGGTACGC	7.84	TAGGTGCGC	6.17
MEX_2	CAediting_892891	chr12_53296554_+	53296549:53296557	5SS	0+3i	TAGGTACGC	7.84	TAGGTGCGC	6.17
ES	CAediting_892893	chr12_53296583_+	53296578:53296586	5SS	0+3i	TTTGTATTA	-11.6	TTTGTGTTA	-19.51
IR	CAediting_892893	chr12_53296583_+	53296578:53296586	5SS	0+3i	TTTGTATTA	-11.6	TTTGTGTTA	-19.51
MEX_2	CAediting_892893	chr12_53296583_+	53296578:53296586	5SS	0+3i	TTTGTATTA	-11.6	TTTGTGTTA	-19.51
IR	CAediting_892929	chr12_53297355_+	53297351:53297373	3SS	0+16i	CCCGAGAGGCAGAGGTTGCAGTG	-40.84	CCCGGGAGGCAGAGGTTGCAGTG	-39.37
IR	CAediting_892930	chr12_53297357_+	53297351:53297373	3SS	0+14i	CCCGAGAGGCAGAGGTTGCAGTG	-40.84	CCCGAGGGGCAGAGGTTGCAGTG	-38.19
IR	CAediting_892931	chr12_53297361_+	53297351:53297373	3SS	0+10i	CCCGAGAGGCAGAGGTTGCAGTG	-40.84	CCCGAGAGGCGGAGGTTGCAGTG	-35.34

Differential percent of spliced in (PSI) between RNA A-to-I edited and non-edited samples for ENSG00000123349.12.PFDN5.

Correlation between RNA A-to-I editing and PSI for ENSG00000123349.12.PFDN5.

Top

Differntial gene expression between RNA A-to-I edited versus non-edited samples for PFDN5

Differential gene expressions between RNA A-to-I edited and non-edited tumor samples.
* The grey color means N/A.

Correlation between RNA A-to-I editing and gene expression.

- Differentially expressed gene between RNA A-to-I edited samples versus non-edited samples.
* Click on the image to enlarge it in a new window.

LAML.CAediting_892895.ENSG00000123349.PFDN5.png
Soverview

Top

Protein coding region RNA A-to-I editings for PFDN5

- Lollipop plot for RNA A-to-I editings across protein structure.
* Click on the image to enlarge it in a new window.

Top

The effects of the RNA editing to the miRNA binding sites for PFDN5

**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page.

RNA A-to-I editing in the 3'-UTR regions of mRNA gained miRNA binding sites.

CAeditom_ID	Position	ENSG	ENST	miRNA	Targetscan start	Targetscan end	Targetscan score	Miranda start	Miranda end	Miranda score	Miranda energy
CAediting_892888	chr12_53296509_+	ENSG00000123349.12	ENST00000550880	hsa-miR-12113	53296502	53296508	7mer-m8	53296485	53296509	150.00	-19.51
CAediting_892888	chr12_53296509_+	ENSG00000123349.12	ENST00000550880	hsa-miR-4539	53296502	53296508	7mer-m8	53296490	53296509	157.00	-22.79
CAediting_892886	chr12_53296489_+	ENSG00000123349.12	ENST00000550880	hsa-miR-485-5p	53296486	53296492	7mer-m8	53296473	53296493	149.00	-16.78
CAediting_892886	chr12_53296489_+	ENSG00000123349.12	ENST00000550880	hsa-miR-604	53296485	53296490	6mer	53296472	53296491	144.00	-23.97
CAediting_892886	chr12_53296489_+	ENSG00000123349.12	ENST00000550880	hsa-miR-6884-5p	53296486	53296492	7mer-m8	53296471	53296493	154.00	-17.69
CAediting_892889	chr12_53296511_+	ENSG00000123349.12	ENST00000550880	hsa-miR-188-5p	53296507	53296513	7mer-m8	53296494	53296514	159.00	-23.99
CAediting_892889	chr12_53296511_+	ENSG00000123349.12	ENST00000550880	hsa-miR-4780	53296505	53296512	8mer-1a	53296491	53296512	149.00	-17.21
CAediting_892889	chr12_53296511_+	ENSG00000123349.12	ENST00000550880	hsa-miR-623	53296506	53296512	7mer-m8	53296490	53296513	144.00	-22.80
CAediting_892889	chr12_53296511_+	ENSG00000123349.12	ENST00000550880	hsa-miR-6866-3p	53296507	53296513	7mer-m8	53296493	53296514	149.00	-11.62

RNA A-to-I editing in the 3'-UTR regions of mRNA lost miRNA binding sites.

CAeditom_ID	Position	ENSG	ENST	miRNA	Targetscan start	Targetscan end	Targetscan score	Miranda start	Miranda end	Miranda score	Miranda energy
CAediting_892889	chr12_53296511_+	ENSG00000123349.12	ENST00000550880	hsa-miR-216b-5p	53296508	53296514	7mer-m8	53296494	53296515	140	-10.16
CAediting_892886	chr12_53296489_+	ENSG00000123349.12	ENST00000550880	hsa-miR-377-5p	53296486	53296492	7mer-m8	53296472	53296493	155	-15.23
CAediting_892886	chr12_53296489_+	ENSG00000123349.12	ENST00000550880	hsa-miR-6086	53296486	53296492	7mer-m8	53296473	53296493	153	-21.13

RNA A-to-I editing in lncRNA gained miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in lncRNA lost miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs gained binding to lncRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs lost binding to lncRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs gained binding to the 3'-UTR region of mRNA.

CAeditom_ID	Position	ENSG	ENST	miRNA	Targetscan start	Targetscan end	Targetscan score	Miranda start	Miranda end	Miranda score	Miranda energy
CAediting_1368054	chr19_46709310_-	ENSG00000123349.12	ENST00000550880	hsa-miR-320e	53298116	53298122	7mer-m8	53298106	53298123	149	-17.88
CAediting_1368054	chr19_46709310_-	ENSG00000123349.12	ENST00000243040	hsa-miR-320e	53298116	53298122	7mer-m8	53298106	53298123	149	-17.88

RNA A-to-I editing in miRNAs lost binding to the 3'-UTR mRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

Differentially expressed gene-miRNA network

Top

The effects of the RNA editing to the stability of the RNA structures for PFDN5

- RNA A-to-I editing in mRNA.
* Click on the image to enlarge it in a new window.

ENST

ENST type

RNA structure without RNA A-to-I editing.

RNA structure with RNA A-to-I editing.

RNA A-to-I editing in RNA structures for Minimum free energy (MFE).

CAeditom_ID

ENST

Editing_Position

MFE_withoneAI

MFE_withoutAI

MFE_withmultipleAI

Top

Relation with ADAR for PFDN5

Correlation between ADAR gene expression and RNA editing frequency

Cancer	CAeditomID	position	ADAR1 (p-val)	ADAR1 (coeff.)	ADAR2 (p-val)	ADAR2 (coeff.)	ADAR3 (p-val)	ADAR3 (coeff.)
BLCA	CAediting_892883	chr12_53296435_+	5.43786587896012e-05	0.226070418241393	.	.	.	.
BRCA	CAediting_892883	chr12_53296435_+	4.68523247832758e-06	0.149888677712628	.	.	.	.
CESC	CAediting_892883	chr12_53296435_+	0.00382110329163108	0.176131410005594	.	.	.	.
LUAD	CAediting_892883	chr12_53296435_+	0.000105385956485338	0.188755740349294	.	.	.	.
COAD	CAediting_892883	chr12_53296435_+	.	.	.	.	0.0184226809016335	0.149583038326123
LUSC	CAediting_892883	chr12_53296435_+	1.77700714066373e-05	0.203246263565954	.	.	.	.
GBM	CAediting_892883	chr12_53296435_+	0.000569580059418401	0.271968000365621	.	.	.	.
PRAD	CAediting_892883	chr12_53296435_+	0.00112971834348744	0.148800615650969	.	.	.	.
HNSC	CAediting_892883	chr12_53296435_+	0.0119207793719363	0.139763943370991	0.0158662774231038	0.134119083433077	.	.
STAD	CAediting_892883	chr12_53296435_+	0.000806691277464394	0.189034211406517	.	.	.	.
THCA	CAediting_892883	chr12_53296435_+	0.000824604316682665	0.148954529182894	.	.	.	.
UCEC	CAediting_892883	chr12_53296435_+	5.50022460256846e-05	0.228813655710099	.	.	.	.
ACC	CAediting_892883	chr12_53296435_+	0.0197805925970917	0.302723333880557	.	.	.	.
OV	CAediting_892883	chr12_53296435_+	0.000148033951970546	0.19732574632801	0.00167015106391077	0.163978834743752	.	.
SKCM	CAediting_892883	chr12_53296435_+	0.0280526462441453	0.114985460304935	.	.	.	.
MESO	CAediting_892883	chr12_53296435_+	0.00254392708594352	0.33922877492887	.	.	0.0438413452945504	0.23036798236649
READ	CAediting_892883	chr12_53296435_+	0.00151686291403706	0.334978520767749	.	.	.	.
BRCA	CAediting_892895	chr12_53296592_+	0.00976412185777282	0.269576370636817	.	.	.	.
GBM	CAediting_892897	chr12_53296612_+	.	.	.	.	0.0454150091167641	0.278710118317565
OV	CAediting_892897	chr12_53296612_+	0.0142020204063432	0.285914278941063	.	.	.	.

Top

Relation with cancer stages for PFDN5

Correlation between Cancer stages and RNA editing frequency

Cancer	Stage_type	CAeditomID	position	P-val	Coeff.
BRCA	pathologic_stage	CAediting_892883	chr12_53296435_+	0.00197347589295741	-0.102554892534315
KIRC	pathologic_stage	CAediting_892883	chr12_53296435_+	0.000321219954232054	0.158991044027249
KIRC	pathologic_stage	CAediting_892895	chr12_53296592_+	0.00282926615421264	0.344625793518621
LIHC	pathologic_stage	CAediting_892883	chr12_53296435_+	0.022569605965832	-0.184912759555034

Top

Relation with survival for PFDN5

Correlation between RNA editing and survival

Cancer	CAeditomID	position	KMpvalue	Coxpvalue	CoxHR
BLCA	CAediting_892883	chr12_53296435_+	0.0467376088597163	0.0462841	3.09632
LUAD	CAediting_892895	chr12_53296592_+	0.00107883787920093	0.032966	13.2232

Top

RelatedDrugs for PFDN5

Approved drugs targeting this gene.
(DrugBank Version 5.1.8 2021-01-03)

Gene

UniProtAcc

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

RelatedDiseases for PFDN5

Diseases associated with this gene.
(DisGeNet 7.0)

Gene

Disease ID

Disease name

# pubmeds

Source

	Gene summary
	RNA A-to-I events
	Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples
	Protein coding region RNA A-to-I editings
	The effects of the RNA editing to the miRNA binding sites
	The effects of the RNA editing to the stability of the RNA structures
	Relation with ADAR
	Relation with cancer stages
	Relation with survival state
	Related drugs with this gene
	Related diseases with this gene